Literature DB >> 1881152

Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.

P Braquet1, D Hosford.   

Abstract

Ginkgolides are unique twenty-carbon terpenes, occurring naturally only in the roots and leaves of Ginkgo biloba. The molecules incorporate a tert-butyl group and six 5-membered rings, and are specific and potent antagonists of platelet-activating factor (PAF), a potent inflammatory autacoid. Studies in animal models with the most potent ginkgolide, BN 52021, and other specific PAF antagonists have demonstrated that PAF plays an important role in pathologies such as asthma, shock, ischemia, anaphylaxis, graft rejection, renal disease, CNS disorders and numerous inflammatory conditions. Ginkgolides are now being developed as therapeutic agents and very promising results have been obtained in clinical trials on shock, organ preservation and thermal injury. In addition to ginkgolides, several other types of natural PAF antagonists have been identified from various medicinal plants. These compounds have not only helped to explain the pharmacological basis of several traditional medicines, but have also provided man with a valuable new class of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881152     DOI: 10.1016/0378-8741(91)90111-p

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

Review 1.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic stroke.

Authors:  Chun-Ling Chi; Dong-Fang Shen; Peng-Jun Wang; Hu-Lun Li; Li Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

4.  An embryo-fetal development toxicity study with dimethylaminoethyl ginkgolide B in rats and rabbits.

Authors:  Ronghua Li; Tingting Zhang; Mei Qin; Peng Yue; Ming Cai; Xuejun He; Hongqun Qiao
Journal:  Toxicol Res (Camb)       Date:  2018-08-28       Impact factor: 3.524

Review 5.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

6.  Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.

Authors:  C Atzori; A Bruno; G Chichino; E Bombardelli; M Scaglia; M Ghione
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Chronic administration of a Ginkgo biloba leaf extract facilitates acquisition but not performance of a working memory task.

Authors:  Elham Satvat; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

8.  Ginkgolides protect primary cortical neurons from potassium cyanide-induced hypoxic injury.

Authors:  Li Zhu; You Jia Xu; Fang Du; Zhong Ming Qian
Journal:  Exp Brain Res       Date:  2007-01-16       Impact factor: 2.064

9.  Inhibitory effects of phylligenin and quebrachitol isolated from Mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation.

Authors:  Bushra Abdulkarim Moharam; Ibrahim Jantan; Juriyati Jalil; Khozirah Shaari
Journal:  Molecules       Date:  2010-11-03       Impact factor: 4.411

Review 10.  Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease.

Authors:  Donald David Haines; Arpad Tosaki
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.